These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37854371)

  • 1. Long-term outcomes of anti-VEGF treatment with 5+PRN regimen for macular edema due to central retinal vein occlusion.
    Ye Y; Deng YM; Huang Z; Wu QW; Hui YN; Song YP
    Int J Ophthalmol; 2023; 16(10):1642-1650. PubMed ID: 37854371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of dexamethasone intravitreal implant in patients with retinal vein occlusion resistant to anti-VEGF therapy: a 12-month prospective study.
    Georgalas L; Tservakis I; Kiskira EE; Petrou P; Papaconstantinou D; Kanakis M
    Cutan Ocul Toxicol; 2019 Dec; 38(4):330-337. PubMed ID: 31060385
    [No Abstract]   [Full Text] [Related]  

  • 3. Combination of Ranibizumab with macular laser for macular edema secondary to branch retinal vein occlusion: one-year results from a randomized controlled double-blind trial.
    Song S; Yu X; Zhang P; Gu X; Dai H
    BMC Ophthalmol; 2020 Jun; 20(1):241. PubMed ID: 32560639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up -- the SOLO study.
    Bezatis A; Spital G; Höhn F; Maier M; Clemens CR; Wachtlin J; Lehmann F; Hattenbach LO; Feltgen N; Meyer CH
    Acta Ophthalmol; 2013 Aug; 91(5):e340-7. PubMed ID: 23638803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and long-term efficacy of repeated dexamethasone intravitreal implants for the treatment of cystoid macular edema secondary to retinal vein occlusion with or without a switch to anti-VEGF agents: a 3-year experience.
    Blanc J; Deschasse C; Kodjikian L; Dot C; Bron AM; Creuzot-Garcher C
    Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1441-1448. PubMed ID: 29855706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-life clinical data for dexamethasone and ranibizumab in the treatment of branch or central retinal vein occlusion over a period of six months.
    Winterhalter S; Eckert A; Vom Brocke GA; Schneider A; Pohlmann D; Pilger D; Joussen AM; Rehak M; Grittner U
    Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):267-279. PubMed ID: 29185099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of visual recovery in patients with macular edema secondary to central retinal vein occlusion after treatment with Conbercept.
    Zhang Q; Hou Y; Cao X; Zhang R; Liu Y; Wei C; Wu C; Mei L; Zhang P
    BMC Ophthalmol; 2021 Nov; 21(1):402. PubMed ID: 34809591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Selective panretinal laser photocoagulation in ischemic central retinal vein occlusion].
    Maltsev DS; Kulikov AN; Burnasheva MA
    Vestn Oftalmol; 2020; 136(6. Vyp. 2):147-154. PubMed ID: 33371643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of intravitreal ranibizumab monotherapy vs. ranibizumab combined with dexamethasone implant for macular edema secondary to retinal vein occlusion.
    Liang X; Shen B; Ou Z; An H; Li L
    Front Med (Lausanne); 2022; 9():930508. PubMed ID: 36172537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of the first 12 months treatment of macular edema complicating BRVO in patients treated with ranibizumab.
    Lalinská L; Krásný J; Studený P; Veith M
    Cesk Slov Oftalmol; 2018; 74(2):62-67. PubMed ID: 30441951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of anti-VEGF results between non-ischemic branch retinal vein occlusion and ischemic branch retinal vein occlusion with early sector panretinal photocoagulation.
    Akdemir SC; Gunay BO
    J Fr Ophtalmol; 2022 Nov; 45(9):1042-1047. PubMed ID: 36127168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of Visual Acuity Outcomes after Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Central Retinal Vein Occlusion.
    Sen P; Gurudas S; Ramu J; Patrao N; Chandra S; Rasheed R; Nicholson L; Peto T; Sivaprasad S; Hykin P
    Ophthalmol Retina; 2021 Nov; 5(11):1115-1124. PubMed ID: 33610836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The short-term efficacy of intravitreal ranibizumab, aflibercept and dexamethasone implant in the treatment of macular edema due to non-ischemic central retinal vein occlusion.
    Yucel OE; Birinci H; Sullu Y
    Int Ophthalmol; 2019 Apr; 39(4):891-901. PubMed ID: 29550932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of a Treat-and-Eextend Regimen of Intravitreal Ranibizumab Injection for Macular Edema due to Branch Retinal Vein Occlusion.
    Hosogi M; Morizane Y; Shiode Y; Doi S; Kumase F; Kimura S; Hosokawa M; Hirano M; Toshima S; Takahashi K; Fujiwara A; Shiraga F
    Acta Med Okayama; 2018 Feb; 72(1):39-45. PubMed ID: 29463937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal anti-VEGF agents, oral glucocorticoids, and laser photocoagulation combination therapy for macular edema secondary to retinal vein occlusion: preliminary report.
    Feng XX; Li C; Shao WW; Yuan YG; Qian XB; Zheng QS; Li YJ; Gao QY
    Int J Ophthalmol; 2018; 11(3):429-437. PubMed ID: 29600177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Conbercept Treatment on Macular Edema and Microvascular Structure in Eyes with Retinal Vein Occlusions.
    Ding X; Wang Y; Zou B; Zang D; Hao Y
    Int J Gen Med; 2022; 15():7311-7318. PubMed ID: 36133911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term effects of intravitreal Conbercept injection combined with laser photocoagulation on macular edema secondary to ischemic retinal vein occlusion.
    Liu ZF; Wang XR; Zhang XY; Pan XM; Zhang RX; Bi HS; Wen Y
    Int J Ophthalmol; 2021; 14(5):732-736. PubMed ID: 34012889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of one and three initial monthly intravitreal ranibizumab injection in patients with macular edema secondary to branch retinal vein occlusion.
    Bayat AH; Çakır A; Özturan ŞG; Bölükbaşı S; Erden B; Elçioğlu MN
    Int J Ophthalmol; 2018; 11(9):1534-1538. PubMed ID: 30225230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-Life Efficacy of Bevacizumab Treatment for Macular Edema Secondary to Central Retinal Vein Occlusion according to
    Hamam M; Lagali N; Abdulnour E; Setterud H; Johansson B; Mirabelli P
    J Ophthalmol; 2022; 2022():6288582. PubMed ID: 36225608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of intravitreal bevacizumab for macular edema following branch retinal vein occlusion stratified by baseline visual acuity.
    Kim M; Jeong S; Sagong M
    Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):691-697. PubMed ID: 27796671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.